Recombinant luteinizing hormone supplementation to recombinant follicle-stimulating hormone induced ovarian hyperstimulation in the GnRH-antagonist multiple-dose protocol

Human Reproduction

Volumn 20, Issue 5, 2005, Pages 1200-1206

  Griesinger, Georg ^a   Schultze Mosgau, A ^a   Dafopoulos, K ^a   Schroeder, A ^a   Schroer, A ^a   von Otte, S ^a   Hornung, D ^a   Diedrich, K ^a   Felberbaum, R ^a  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

Cetrorelix; GnRH antagonist; Ovarian stimulation; Recombinant FSH; Recombinant LH

Indexed keywords

CETRORELIX; CHORIONIC GONADOTROPIN; ESTRADIOL; RECOMBINANT CHORIONIC GONADOTROPIN; RECOMBINANT FOLLITROPIN; RECOMBINANT LUTEINIZING HORMONE;

ADULT; ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ESTRADIOL BLOOD LEVEL; FEMALE; FEMALE INFERTILITY; FERTILIZATION IN VITRO; HUMAN; INTRACYTOPLASMIC SPERM INJECTION; MAJOR CLINICAL STUDY; MULTIPLE DRUG DOSE; OVARY FOLLICLE; OVARY HYPERSTIMULATION; PREGNANCY RATE; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE;

EID: 20344374631     PISSN: 02681161     EISSN: None     Source Type: Journal    
DOI: 10.1093/humrep/deh741     Document Type: Article

References (30)

1. Aboulghar MA, Mansour RT, Serour GI, Al-Inany HG, Amin YM and Aboulghar MM (2004) Increasing the dose of human menopausal gonadotrophins on day of GnRH antagonist administration: randomized controlled trial. Reprod Biomed Online 8,524-527.
2. Albano C, Smitz J, Camus M, Riethmuller-Winzen H, Van Steirteghem A and Devroey P (1997) Comparison of different doses of gonadotropin-releasing hormone antagonist Cetrorelix during controlled ovarian hyperstimulation. Fertil Steril 67,917-922.
3. Al-Inany H and Aboulghar M (2003) Gonadotrophin-releasing hormone antagonists for assisted conception (Cochrane Review). In The Cochrane Library, Issue 1. Update Software, Oxford.
4. Balasch J, Vidal E, Penarrubia J, Casamitjana R, Carmona F, Creus M, Fabregues F and Vanrell JA (2001) Suppression of LH during ovarian stimulation: analysing threshold values and effects on ovarian response and the outcome of assisted reproduction in down-regulated women stimulated with recombinant FSH. Hum Reprod 16,1636-1643.
5. Balasch J, Penarrubia J, Fabregues F, Vidal E, Casamitjana R, Manau D, Carmona F, Creus M and Vanrell JA (2003) Ovarian responses to recombinant FSH or HMG in normogonadotrophic women following pituitary desensitization by a depot GnRH agonist for assisted reproduction. Reprod Biomed Online 7,35-42.
6. Cedrin-Durnerin I, Grange-Dujardin D, Laffy A et al. (2004) Recombinant human LH supplementation during GnRH antagonist administration in IVF/ICSI cycles: a prospective randomized study. Hum Reprod 19, 1979-1984.
7. Chappel SC and Howles C (1991) Reevaluation of the roles of luteinizing hormone and follicle-stimulating hormone in the ovulatory process. Hum Reprod 6,1206-1212.
8. Coppola F, Poti ER, Barusi L, Ferrari B, Salvarani MC and Vadora E (2003) Profound luteinizing hormone suppression induces a deleterious follicular environment during assisted reproduction technology. Fertil Steril 79, 459-460.
9. Erickson GF, Wang C and Hsueh AJ (1979) FSH induction of functional LH receptors in granulosa cells cultured in a chemically defined medium. Nature 279,336-338.
10. Esposito MA, Barnhart KT, Coutifaris C and Patrizio P (2001) Role of periovulatory luteinizing hormone concentrations during assisted reproductive technology cycles stimulated exclusively with recombinant follicle-stimulating hormone. Fertil Steril 75,519-524.
11. European Recombinant Human, L.H. Study Group (1998) Recombinant human luteinizing hormone (LH) to support recombinant human follicle-stimulating hormone (FSH)-induced follicular development in LH- and FSH-deficient anovulatory women: a dose-finding study. J Clin Endocrinol Metab 83,1507-1514.
12. Filicori M, Cognigni GE, Taraborrelli S, Spettoli D, Ciampaglia W, de Fatis CT and Pocognoli P (1998) Luteinizing hormone activity supplementation enhances follicle-stimulating hormone efficacy and improves ovulation induction outcome. J Clin Endocrinol Metab 84,2659-2663.
13. Filicori M, Cognigni GE, Pocognoli P, Tabarelli C, Ferlini F, Perri T and Parmegiani L (2003) Comparison of controlled ovarian stimulation with human menopausal gonadotropin or recombinant follicle-stimulating hormone. Fertil Steril 80,390-397.
14. Finas D, Felberbaum R, Roiha K, Wiese J, Schultze-Mosgau A, Griesinger G, Kuepker W and Diedrich K (2003) LH-pulsatility profiles within 24 h after first administration of the GnRH-antagonist Cetrorelix (0.25 mg) on day 6 of stimulation. In Abstracts of the 19th Annual Meeting of the ESHRE, Madrid, Spain, p. xviii 172.
15. Fleming R, Lloyd F, Herbert M, Fenwick, J Griffiths, T and Murdoch A (1998) Effects of profound suppression of luteinizing hormone during ovarian stimulation on follicular activity, oocyte and embryo function in cycles stimulated with purified follicle stimulating hormone. Hum Reprod 137,1788-1792.
16. Fleming R, Rehka P, Deshpande N, Jamieson ME, Yates RW and Lyall H (2000) Suppression of LH during ovarian stimulation: effects differ in cycles stimulated with purified urinary FSH and recombinant FSH. Hum Reprod 15,1440-1445.
17. Ganirelix dose-finding study group (1998) A double-blind, randomized, dose-finding study to assess the efficacy of the gonadotrophin-releasing hormone antagonist ganirelix (Org 37462) to prevent premature luteinizing hormone surges in women undergoing ovarian stimulation with recombinant follicle stimulating hormone (Puregon). Hum Reprod 13,3023-3031.
18. Hull MG, Armatage RJ and McDermott A (1994) Use of follicle-stimulating hormone alone (urofollitropin) to stimulate the ovaries for assisted conception after pituitary desensitization. Fertil Steril 62,997-1003.
19. Humaidan P, Bungum L, Bungum M and Andersen CY (2002) Ovarian response and pregnancy outcome related to mid-follicular LH levels in women undergoing assisted reproduction with GnRH agonist down-regulation and recombinant FSH stimulation. Hum Reprod 17,2016-2021.
20. Humaidan P, Bungum M, Bungum L and Yding Andersen C (2004) Effects of recombinant LH supplementation in women undergoing assisted reproduction with GnRH agonist down-regulation and stimulation with recombinant FSH: an opening study. Reprod Biomed Online 8,635-643.
21. Kolibianakis EM, Albano C, Camus M, Tournaye H, Van Steirteghem AC and Devroey P (2003) Relationship between LH and oestradiol in IVF cycles before GnRH antagonist initiation. Reprod Biomed Online 7, 190-193.
22. Kolibianakis EM, Zikopoulos K, Schiettecatte J, Smitz J, Tournaye H, Camus M, Van Steirteghem AC and Devroey P (2004) Profound LH suppression after GnRH antagonist administration is associated with a significantly higher ongoing pregnancy rate in IVF. Hum Reprod 19 [Epub ahead of print].
23. Levy DP, Navarro JM, Schattman GL, Davis OK and Rosenwaks Z (2000) The role of LH in ovarian stimulation: exogenous LH: let's design the future. Hum Reprod 15,2258-2265.
24. Loumaye E, Engrand P, Howles CM and O'Dea L (1997) Assessment of the role of serum luteinizing hormone and estradiol response to follicle-stimulating hormone on in vitro fertilization treatment outcome. Fertil Steril 67,889-899.
25. Ludwig M, Schoepper B, Katalinic A, Sturm R, Al-Hasani S and Diedrich K (2000) Experience with the elective transfer of two embryos under the conditions of the German Embryo Protection Law: results of a retrospective data analysis of 2573 transfer cycles. Hum Reprod 15,319-324.
26. Ludwig M, Katalinic A, Banz C, Schroder AK, Loning M, Weiss JM and Diedrich K (2002) Tailoring the GnRH antagonist cetrorelix acetate to individual patients' needs in ovarian stimulation for IVF: results of a prospective, randomized study. Hum Reprod 17,2842-2845.
27. Marrs R, Meldrum D, Muasher S, Schoolcraft W, Werlin L and Kelly E (2004) Randomized trial to compare the effect of recombinant human FSH (follitropin alfa) with or without recombinant human LH in women undergoing assisted reproduction treatment. Reprod Biomed Online 8,175-182.
28. Merviel P, Antoine JM, Mathieu E, Millot F, Mandelbaum J and Uzan S (2004) Luteinizing hormone concentrations after gonadotropin-releasing hormone antagonist administration do not influence pregnancy rates in in vitro fertilization-embryo transfer. Fertil Steril 82,119-125.
29. Penarrubia J, Fabregues F, Creus M, Marian D, Casamitjana R, Guimera M, Carmona, F, Vanrell JA and Balasch J (2003) LH serum levels during ovarian stimulation as predictors of ovarian response and assisted reproduction outcome in down-regulated women stimulated with recombinant FSH. Hum Reprod 18,2689-2697.
30. Westergaard LG, Laursen SB and Andersen CY (2000) Increased risk of early pregnancy loss by profound suppression of luteinizing hormone during ovarian stimulation in normogonadotrophic, women undergoing assisted reproduction. Hum Reprod 15,1003-1008.